The treatment of chronic cystitis with combination with papillomavirus infection and urogenital herpes 1 and 2

   Cystitis is not only a frequent and repeatedly relapsing disease, but also a socially significant disease that significantly worsens the patient's quality of life. In practical work, we quite often met patients with such pronounced dysuric phenomena and hematuria that a sick leave certificate was required for the course of treatment. The article analyzes the results of treatment of 96 patients diagnosed with chronic cystitis with concomitant diagnoses of papillomavirus infection (human papillomavirus) and urogenital herpes (herpes simplex virus) types 1 and 2.

   The aim of the work was to evaluate the effectiveness of complex therapy for acute or chronic cystitis.

   40 patients suffering from chronic cystitis on the background of herpetic viral infection and 50 patients with chronic cystitis on the background of human papillomavirus infection were treated. The prescription of drugs for the treatment of a chronic inflammatory process in the bladder was carried out in accordance with the Russian clinical guidelines of 2016. Patients received antibacterial therapy with Furamag 50, and alternative drugs Ciprofloxacin 500 and Levofloxacin 500 were used. When a herpes viral infection was detected, we used the antiviral drug Acyclovir 200 In case of detection of papillomavirus infection, Isoprinosine 500 was prescribed. In the treatment of patients in both groups, the immunomodulator Tubosan 200 mg was used. As a result of the therapy, the patients achieved remission of chronic cystitis or its complete cure, confirmed by clinical and laboratory data. At the end of treatment, a decrease or complete absence of the viral load of human papillomavirus and herpes simplex virus was also observed. No significant side effects were noted during treatment. Thus, Tubosan can be used as an immunotropic agent in the complex therapy of acute and chronic cystitis to improve the outcome of treatment.

1. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Российские национальные рекомендации. – M., 2012. [Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Russian national recommendations. M., 2012.]

2. Довлетханова Э. Р. Эффективность и приемлемость лечения ВПЧ-ассоциированных заболеваний мочевого пузыря / Э. Р. Довлетханова // Урология. – 2018. – 3. – 50-53. [Dovletkhanova E. R. Effectiveness and acceptability of treatment of HPV-associated bladder diseases // Urologiya. 2018; 3: 50-53.]

3. Ибишев Х. С Лечение крупных рецидивирующих остроконечных кондилом наружных гениталий у женщин //Х. С. Ибишев, М. И. Коган // Урология. – 2013. – 6. – 56-59. [Ibishev Kh. S, Kogan M. I. Treatment of large recurrent genital warts of the external genitalia in women // Urologiya. 2013; 6: 56-59.]

4. Клинические рекомендации РОДВК по ведению больных инфекциями, передаваемыми половым путем, и урогенитальными инфекциями. – М.: Издательский дом Деловой Экспресс, 2012. – 112 с. [Clinical recommendations of the RODVK on the management of patients with sexually transmitted infections and urogenital infections. – M.: Izdatel'skiy dom Delovoy Ekspress, 2012. – Р. 112.]

5. Ламоткин И. А. Опыт применения препарата Мардил Цинк® Макс в лечении доброкачественных новообразований кожи / И. А. Ламоткин [и др.] // Военно-медицинский журнал. – 2015. – 11: 58-60. [Lamotkin I. A., Ushakov I. I., Mardi Sh. I., Selezneva Ye. V., Khlebnikova A. N. Experience with the use of Mardil Zinc® Max in the treatment of benign skin neoplasms // Voyenno-meditsinskiy zhurnal. 2015; 11: 58-60.]

6. Лоран О. Б. Рецидивирующие инфекции мочевых путей. Алгоритм диагностики и лечения / О. Б. Лоран, Л. А. Синякова, И. В. Косова. – М.: МИА, 2008. – 29 с. [Loran O. B., Sinyakova L. A., Kosova I. V. Recurrent urinary tract infections. Algorithm for diagnosis and treatment. M.: MIA, 2008. 29 р.]

7. Молочков А. В. Препарат Панавир в терапии новообразований кожи, ассоциированных с папилломавирусной инфекцией / А. В. Молочков, Г. Э. Баграмова, М. А. Гуреева // Альманах клинической медицины. – 2018. – 46 (1): 24-28. [Molochkov A. V. Bagramova G. E. Gureyeva M. A. Panavir in the treatment of skin neoplasms associated with human papillomavirus infection // Al'manakh klinicheskoy meditsiny. 2018: 46 (1): 24-28.]

8. Рахматулина М. Р. Особенности клинического течения папилломавирусной инфекции в зависимости от генотипа и количественных показателей вирусов папилломы человека высокого онкогенного риска / М. Р. Рахматулина, Н. В. Большенко // Вестник дерматологии и венерологии. – 2014. – 3. – 95-105. [Rakhmatulina M. R., Bol'shenko N. V. Features of the clinical course of human papillomavirus infection depending on the genotype and quantitative indicators of human papillomaviruses of high oncogenic risk // Vestnik dermatologii i venerologii. 2014; 3: 95-105.]

9. Рахматулина М. Р. Эпизодическая терапия рецидивирующей герпетической инфекции: результаты проспективного постмаркетингового исследования / М. Р. Рахматулина // Вестник дерматологии и венерологии. – 2009. – 5: 120-124. [Rakhmatulina M. R. Episodic therapy of recurrent herpetic infection: results of a prospective post-marketing study. // Vestnik dermatologii i venerologii. 2009; 5: 120-124.]

10. Роговская С. И. Генитальные кондиломы: терапия и профилактика / С. И. Роговская, Н. М. Подзолкова, А. Н. Оламова // Врач. – 2010. – 12. – 48-51. [Rogovskaya S. I., Podzolkova N. M., Olamova A. N. Genital condylomas: therapy and prevention // Vrach. 2010; 12: 48-51.]

11. Alidjanov J. F., Abdufattaev U. A., Makhsudov S. A., Pilatz A., Akilov F. A., Naber K. G., Wagenlehner F. M. New Self-Reporting Questionnaire to Assess Urinary Tract Infections and Differential Diagnosis: Acute Cystitis Symptom Score // Urologia Internationalis. 2014; 92 (2): 230-236. DOI: 10.1159/000356177.

12. Bodsworth N., Bloch M., McNulty A., 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study // Sexual Health. 2008; 5 (3): 219-225.

13. Hollier L. M., Wendel G. D. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplx virus (HSV) recurrences and neonatal infection // Cochrane Database of Systematic Reviews. 2008, Issue 1.

14. Hooton T. M. Recurrent urinary tract infection in women // Int. J. Antimicrob. Agents 2001; 17 (4): 259-268.

15. Komericki P., Akkilic-Materna M., Strimitzer T., Aberer W. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of genital warts // Sex Transm Dis. 2011; 38: 216-218.